Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excimer laser photorefractive keratectomy for hyperopia.

E Pacella1, S Abdolrahimzadeh, C B Gabrieli

  • 1Istituto di Oftalmologia, Università di Roma La Sapienza, Italy.

Ophthalmic Surgery and Lasers
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Papilledema in childhood for diagnosis of pseudotumor cerebri or late hydrocephalus: a case report.

La Clinica terapeutica·2023
Same author

Nab-Paclitaxel related cystoid macular edema.

La Clinica terapeutica·2022
Same author

Telework and its effects on mental health during the COVID-19 lockdown.

European review for medical and pharmacological sciences·2021
Same author

Medico legal considerations on refractive surgery.

La Clinica terapeutica·2020
Same author

Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion.

La Clinica terapeutica·2020

Photorefractive keratectomy (PRK) effectively corrects hyperopia, with most patients achieving vision within 1 D of emmetropia at 18 months. This refractive surgery offers a safe and reliable option for hyperopic correction.

Area of Science:

  • Ophthalmology
  • Refractive Surgery
  • Corneal Surgery

Background:

  • Photorefractive keratectomy (PRK) is a well-established procedure for myopia correction.
  • Its application in hyperopia correction requires further safety and efficacy assessment.

Purpose of the Study:

  • To evaluate the safety, efficacy, and reliability of PRK for hyperopia correction.
  • To assess visual outcomes and complications up to 18 months post-treatment.

Main Methods:

  • 28 eyes with hyperopia (+1 to +7.75 D) underwent PRK using the Chiron Technolas 217-C excimer laser.
  • Comprehensive visual assessments and complication monitoring were performed up to 18 months.

Main Results:

  • At 18 months, 92.8% of eyes were within 1 D of emmetropia.

Related Experiment Videos

  • 46.4% achieved uncorrected visual acuity (UCVA) of 20/20 or better; all had UCVA ≥ 20/32.
  • Best corrected visual acuity (BCVA) was stable or improved in all eyes, with no significant BCVA loss at 18 months.

    • Conclusions:

    • PRK is a safe and effective method for reducing hyperopia.
    • The procedure demonstrates reliability with sustained positive outcomes at 18 months.